Diagnosis
AI to check breast cancer scans in groundbreaking NHS trial
The technology could help doctors find malignancies in mammograms, freeing up clinical time

NHS patients in England will be part of a new groundbreaking trial using AI to support breast screening.
The programme, called MIA (mammography intelligent assessment), is developed by the London-based software company, Kheiron Medical, and uses AI to help radiologists identify signs of breast cancer.
The algorithm has already been used on half a million scans from hospitals in Hungary, but it is new to the UK.
According to the Times, MIA will work alongside two members of the breast screening reading team at Leeds Teaching Hospitals NHS Trust to check mammograms from almost 7,000 women.
During the trial, also known as Libra, if the two humans and AI reader all agree a mammogram is normal, the patient will receive the all-clear.
If any of the three disagree, another radiologist will review the scan before deciding whether or not to recall the patient for further checks.
“Breast screening isn’t perfect and it is hoped that the Libra study will lead to improvements in reviewing mammograms,” Dr Nisha Sharma, a consultant breast radiologist at the trust and director of the breast screening programme for Leeds and Wakefield, told the newspaper.
“Cancers that present between screening rounds are often quite aggressive and the reason these can be overlooked is because they are not clearly visible on a mammogram.
“AI works differently to humans and by combining human expertise with technology advances this could lead to earlier detection of cancers and impact positively on women’s lives. We will be the first breast screening unit in England to do a prospective study using AI.”
Simon Harris, senior project manager at Kheiron Medical Technologies, said: “The NHS does not have enough radiologists which is leading to delays in readings and diagnoses and workforce burnout.
“To solve this problem, we are looking at how AI software could replace the second human reader and release that person to do something more clinically urgent.
“We want to demystify what AI is. It is just a piece of software that’s very good at picking up certain patterns that it recognises in images and coming back with an output.”
The UK is currently short of 1,669 clinical radiologists, and over 200 vacancies have been unfilled for a year or more, according to the annual census released in June 2022 by the Royal College of Radiologists (RCR).
Unless urgent action is taken, the shortfall could hit 39 per cent by 2026, equal to 3,166 clinical radiologists, the report has found.
If successful, Mia could replace one of the two human readers in standard NHS care, reducing the burden on the health system.
Diagnosis
WHO launches AI tool for reproductive health information

The World Health Organization (WHO) has launched an AI tool in beta to help policymakers, experts and healthcare professionals access sexual and reproductive health information faster.
Called ChatHRP, the tool was created by WHO’s Human Reproduction Programme and draws only on verified research and guidance collected by HRP and WHO.
It uses natural language processing and retrieval-augmented generation to produce referenced content and cut the time spent searching through documents across different platforms and databases.
WHO said ChatHRP also has multilingual capabilities and low-bandwidth functionality to support use in a wide range of settings.
The beta-testing phase is aimed at a broad professional audience, including policymakers, healthcare workers, researchers and civil society groups.
WHO said the tool can help users quickly access up-to-date evidence, find sources for academic work and verify information on sexual and reproductive health and rights.
Examples of questions it can answer include the latest violence against women data in Oceania for women aged 15 to 49, recommendations on managing diabetes during pregnancy, and whether PrEP and contraception can be used at the same time. PrEP is medicine used to reduce the risk of getting HIV.
WHO added that the system will be updated regularly as new HRP materials are published and includes a feedback loop so users can flag gaps in the information provided.
The launch comes amid wider concern about misinformation in sexual and reproductive health.
A 2025 scoping review found that misinformation in digital spaces is a systemic issue that can undermine human rights, reinforce discriminatory social norms and exclude marginalised voices.
The review also said misinformation can affect health systems by shaping provider knowledge and practice, disrupting service delivery and creating barriers to equitable care.
WHO said ChatHRP is intended to give users streamlined access to reliable information as a counter to “algorithms, opinions, or misinformation”.
Menopause
AI maps how reproductive organs age differently during menopause
Pregnancy
Early miscarriage care could prevent 10,000 pregnancy losses a year, study finds
Entrepreneur2 weeks agoFuture Fertility raises Series A financing to scale AI tools redefining fertility care worldwide
News1 week agoWomen’s digital health market set to reach US$5.28 billion in 2026 – report
Fertility3 weeks agoFuture Fertility partners with Japan’s leading IVF provider, Kato Ladies Clinic
Menopause3 weeks agoMore research needed to understand link between brain fog and menopause, expert says
Mental health2 weeks agoLifting weights shows mental health and cognitive benefits in older women, study finds
News4 weeks agoSelf-employment linked to better cardiovascular health outcomes in Hispanic women
Entrepreneur3 weeks agoFlora Fertility closes US$5m seed round
News2 weeks agoResistance training has preventative effects in menopause, study finds
















Pingback: NHS approves ‘life-saving’ AstraZeneca drug for breast cancer - FemTech World